HYDROCHLOROTHIAZIDE

HYDROCHLOROTHIAZIDE was reported 146341 times

HYDROCHLOROTHIAZIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CARDIOSPASM 403 0.7222
1 VAGINAL FLATULENCE 190 0.6271
2 IMMUNISATION 260 0.5991
3 PALMOPLANTAR KERATODERMA 391 0.5393
4 NEUROLOGIC NEGLECT SYNDROME 182 0.3273
5 TOTAL LUNG CAPACITY ABNORMAL 110 0.2828
6 PULMONARY VASCULITIS 137 0.2546
7 AMAUROSIS FUGAX 245 0.2275
8 CAROTID ARTERY THROMBOSIS 186 0.2191
9 ATRIAL TACHYCARDIA 442 0.2103
10 PRURITUS GENITAL 413 0.1752
11 SPIROMETRY ABNORMAL 103 0.1722
12 MITE ALLERGY 107 0.1634
13 ADJUSTMENT DISORDER 187 0.1438
14 CAROTID ARTERY OCCLUSION 487 0.1334
15 MYCOTIC ALLERGY 107 0.1251
16 FEMALE GENITAL TRACT FISTULA 209 0.1223
17 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 124 0.1168
18 NEPHROGENIC ANAEMIA 531 0.1145
19 DUST ALLERGY 109 0.1111
20 HYPERPARATHYROIDISM SECONDARY 270 0.1077
21 NEURITIS 158 0.1023
22 TENSION HEADACHE 440 0.1022
23 RADICULOPATHY 263 0.0997
24 SLEEP TERROR 409 0.0970
25 CHRONIC SINUSITIS 350 0.0932
26 REBOUND ACID HYPERSECRETION 263 0.0869
27 BLOOD PRESSURE SYSTOLIC ABNORMAL 201 0.0812
28 PROCTITIS 214 0.0763
29 PERSONALITY DISORDER 199 0.0759
30 MACULAR DEGENERATION 899 0.0752
31 CONJUNCTIVITIS ALLERGIC 110 0.0742
32 ESSENTIAL HYPERTENSION 131 0.0715
33 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 139 0.0681
34 BLOOD PRESSURE DIASTOLIC ABNORMAL 172 0.0676
35 METABOLIC ALKALOSIS 104 0.0648
36 FACIAL PAIN 551 0.0617
37 BLOOD PRESSURE DIASTOLIC DECREASED 416 0.0563
38 HAEMORRHAGIC STROKE 437 0.0559
39 URINARY TRACT DISORDER 252 0.0559
40 FORCED EXPIRATORY VOLUME DECREASED 158 0.0557
41 VASCULITIS 642 0.0551
42 RESPIRATORY SYMPTOM 155 0.0544
43 HYPONATRAEMIA 2963 0.0525
44 ARTERIOSCLEROSIS CORONARY ARTERY 336 0.0507
45 SUBARACHNOID HAEMORRHAGE 510 0.0500
46 END STAGE RENAL DISEASE 899 0.0492
47 LEFT VENTRICULAR HYPERTROPHY 209 0.0488
48 HYPOVOLAEMIA 284 0.0485
49 NORMOCHROMIC NORMOCYTIC ANAEMIA 145 0.0482
50 CHRONIC KIDNEY DISEASE 3479 0.0457
51 BLOOD CHLORIDE DECREASED 117 0.0453
52 HYPOKALAEMIA 2081 0.0450
53 SUPRAVENTRICULAR EXTRASYSTOLES 152 0.0450
54 CAROTID ARTERY STENOSIS 156 0.0446
55 SPRUE-LIKE ENTEROPATHY 211 0.0428
56 ACTINIC KERATOSIS 110 0.0423
57 BLOOD PRESSURE SYSTOLIC INCREASED 823 0.0422
58 DIASTOLIC DYSFUNCTION 130 0.0421
59 BLOOD POTASSIUM DECREASED 1256 0.0417
60 BLOOD PRESSURE INADEQUATELY CONTROLLED 250 0.0415
61 BUNDLE BRANCH BLOCK LEFT 176 0.0415
62 ATRIOVENTRICULAR BLOCK FIRST DEGREE 179 0.0413
63 DIABETIC NEUROPATHY 203 0.0410
64 LOSS OF EMPLOYMENT 122 0.0404
65 ARTERIAL OCCLUSIVE DISEASE 316 0.0402
66 OBSTRUCTIVE AIRWAYS DISORDER 446 0.0401
67 PSYCHOLOGICAL TRAUMA 338 0.0391
68 HYPERCALCAEMIA 474 0.0383
69 SPINAL OSTEOARTHRITIS 335 0.0381
70 GANGRENE 229 0.0380
71 AORTIC VALVE INCOMPETENCE 159 0.0373
72 VENTRICULAR TACHYCARDIA 610 0.0369
73 HYPERLIPIDAEMIA 430 0.0359
74 ARTERIOSCLEROSIS 336 0.0357
75 SENSORY LOSS 280 0.0347
76 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 357 0.0347
77 TRICUSPID VALVE INCOMPETENCE 271 0.0341
78 DIPLOPIA 885 0.0340
79 BREATH SOUNDS ABNORMAL 168 0.0340
80 DIVERTICULUM 242 0.0340
81 HAIR DISORDER 280 0.0339
82 ANOSMIA 490 0.0338
83 NEUROLOGICAL SYMPTOM 193 0.0337
84 ACUTE KIDNEY INJURY 5154 0.0336
85 POLYP 220 0.0336
86 SINUS CONGESTION 450 0.0333
87 MITRAL VALVE INCOMPETENCE 372 0.0328
88 PEPTIC ULCER 109 0.0328
89 DIVERTICULUM INTESTINAL 143 0.0327
90 BLOOD PRESSURE DIASTOLIC INCREASED 149 0.0323
91 MOTOR DYSFUNCTION 326 0.0320
92 OCULAR DISCOMFORT 359 0.0319
93 HEMIPLEGIA 265 0.0318
94 RENAL TUBULAR NECROSIS 311 0.0317
95 GENERALISED OEDEMA 392 0.0316
96 FULL BLOOD COUNT ABNORMAL 330 0.0312
97 SLEEP APNOEA SYNDROME 583 0.0305
98 HAIR COLOUR CHANGES 380 0.0305
99 BODY TEMPERATURE DECREASED 300 0.0304
100 BLOOD SODIUM DECREASED 573 0.0304
101 RENAL CYST 241 0.0303
102 TRANSIENT ISCHAEMIC ATTACK 1022 0.0303
103 BASAL CELL CARCINOMA 471 0.0302
104 HYPOMAGNESAEMIA 420 0.0301
105 RENAL INJURY 887 0.0298
106 SPINAL COLUMN STENOSIS 141 0.0298
107 PULMONARY ALVEOLAR HAEMORRHAGE 166 0.0296
108 PERIPHERAL VASCULAR DISORDER 150 0.0291
109 OSTEOARTHRITIS 1228 0.0289
110 RENAL FAILURE CHRONIC 222 0.0288
111 PERICARDITIS 482 0.0287
112 LACTIC ACIDOSIS 927 0.0286
113 TUBULOINTERSTITIAL NEPHRITIS 535 0.0285
114 PRE-EXISTING CONDITION IMPROVED 178 0.0285
115 HEPATIC STEATOSIS 531 0.0285
116 BLOOD PRESSURE FLUCTUATION 678 0.0282
117 RALES 164 0.0282
118 CARDIOMEGALY 347 0.0282
119 ELECTROCARDIOGRAM ABNORMAL 220 0.0280
120 BLOOD CREATINE INCREASED 124 0.0280
121 INTERVERTEBRAL DISC DISORDER 119 0.0278
122 INTERVERTEBRAL DISC DEGENERATION 257 0.0277
123 SINUS BRADYCARDIA 268 0.0277
124 BLOOD PRESSURE INCREASED 4223 0.0276
125 ORAL CANDIDIASIS 363 0.0275
126 HYPERKERATOSIS 152 0.0275
127 SNORING 104 0.0275
128 CORONARY ARTERY DISEASE 817 0.0270
129 LARGE INTESTINE POLYP 184 0.0265
130 PARAESTHESIA ORAL 382 0.0265
131 MUSCLE TWITCHING 608 0.0264
132 BLOOD UREA INCREASED 437 0.0261
133 ANGINA UNSTABLE 168 0.0258
134 HAIR TEXTURE ABNORMAL 344 0.0257
135 TINNITUS 1179 0.0256
136 RENAL FAILURE ACUTE 1081 0.0254
137 ATELECTASIS 246 0.0254
138 HIATUS HERNIA 329 0.0254
139 SINUS DISORDER 503 0.0254
140 IRON DEFICIENCY 114 0.0253
141 RESPIRATORY TRACT CONGESTION 400 0.0252
142 UPPER-AIRWAY COUGH SYNDROME 207 0.0251
143 BUNDLE BRANCH BLOCK RIGHT 115 0.0250
144 COORDINATION ABNORMAL 348 0.0249
145 MENISCUS INJURY 153 0.0249
146 CARDIAC MURMUR 215 0.0248
147 RENAL FAILURE 3287 0.0247
148 RHINITIS ALLERGIC 110 0.0247
149 GLUCOSE TOLERANCE IMPAIRED 146 0.0247
150 BODY HEIGHT DECREASED 262 0.0245
151 HEAD DISCOMFORT 433 0.0244
152 ROTATOR CUFF SYNDROME 314 0.0244
153 ANGIOEDEMA 1079 0.0244
154 BLOOD MAGNESIUM DECREASED 210 0.0243
155 AFFECT LABILITY 234 0.0243
156 SKIN HAEMORRHAGE 359 0.0242
157 MADAROSIS 281 0.0242
158 INTERVERTEBRAL DISC PROTRUSION 526 0.0240
159 CORONARY ARTERY STENOSIS 121 0.0240
160 PANCREATITIS ACUTE 539 0.0240
161 JOINT EFFUSION 165 0.0239
162 HYPERTENSIVE CRISIS 266 0.0239
163 ECONOMIC PROBLEM 361 0.0238
164 VAGINAL DISCHARGE 241 0.0238
165 HEMIPARESIS 403 0.0238
166 GOUT 425 0.0237
167 TOOTH ABSCESS 241 0.0236
168 GASTROOESOPHAGEAL REFLUX DISEASE 1905 0.0236
169 BENIGN PROSTATIC HYPERPLASIA 122 0.0236
170 EATING DISORDER 503 0.0236
171 VENTRICULAR EXTRASYSTOLES 245 0.0236
172 ONYCHOMYCOSIS 103 0.0235
173 ORTHOSTATIC HYPOTENSION 408 0.0234
174 BLINDNESS 952 0.0233
175 PRESYNCOPE 568 0.0233
176 HYPERTENSION 4911 0.0232
177 BLOOD CHOLESTEROL ABNORMAL 107 0.0231
178 NEPHROPATHY 216 0.0231
179 CARPAL TUNNEL SYNDROME 324 0.0231
180 POLYURIA 189 0.0231
181 NODULE 300 0.0230
182 ANHEDONIA 603 0.0229
183 HYPERKALAEMIA 803 0.0229
184 HAEMATOCRIT DECREASED 453 0.0228
185 DYSLIPIDAEMIA 116 0.0228
186 NOCTURIA 274 0.0225
187 ELECTROLYTE IMBALANCE 262 0.0225
188 ANGINA PECTORIS 645 0.0225
189 SQUAMOUS CELL CARCINOMA 210 0.0223
190 LIP SWELLING 742 0.0223
191 LEFT VENTRICULAR DYSFUNCTION 149 0.0222
192 DEHYDRATION 2962 0.0222
193 RENAL FUNCTION TEST ABNORMAL 103 0.0222
194 SCOLIOSIS 137 0.0221
195 FLANK PAIN 206 0.0220
196 HEART RATE DECREASED 770 0.0219
197 HYPERNATRAEMIA 109 0.0219
198 OSTEOPENIA 331 0.0218
199 HYPERCHOLESTEROLAEMIA 210 0.0217
200 RASH PAPULAR 487 0.0217
201 EXOSTOSIS 198 0.0217
202 MUSCLE SPASTICITY 266 0.0216
203 SKIN NECROSIS 112 0.0216
204 CYSTITIS 687 0.0216
205 BLOOD TRIGLYCERIDES INCREASED 379 0.0214
206 MYOPATHY 184 0.0213
207 GLOMERULAR FILTRATION RATE DECREASED 261 0.0212
208 NERVE COMPRESSION 196 0.0212
209 EMPHYSEMA 214 0.0212
210 TORSADE DE POINTES 166 0.0211
211 HEART RATE IRREGULAR 476 0.0210
212 RED BLOOD CELL SEDIMENTATION RATE INCREASED 233 0.0210
213 TYPE 2 DIABETES MELLITUS 708 0.0210
214 PHOTOPHOBIA 395 0.0210
215 SYNCOPE 2098 0.0209
216 OBESITY 334 0.0209
217 BURSITIS 254 0.0209
218 DIABETES MELLITUS INADEQUATE CONTROL 370 0.0209
219 PULMONARY FIBROSIS 400 0.0208
220 HAEMORRHOIDS 406 0.0208
221 BLOOD CHOLESTEROL INCREASED 967 0.0207
222 OEDEMA PERIPHERAL 2512 0.0206
223 OSTEOPOROSIS 845 0.0205
224 EOSINOPHIL COUNT INCREASED 171 0.0205
225 DIVERTICULITIS 568 0.0205
226 CARDIAC VALVE DISEASE 117 0.0204
227 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 347 0.0204
228 SNEEZING 458 0.0204
229 SKIN LACERATION 222 0.0204
230 PEMPHIGOID 153 0.0203
231 CATARACT 1200 0.0201
232 PAIN OF SKIN 542 0.0201
233 PULMONARY MASS 299 0.0201
234 BLOOD PRESSURE ABNORMAL 399 0.0200
235 URINE ODOUR ABNORMAL 118 0.0200
236 NEUTROPHILIA 114 0.0200
237 ARTHRITIS 1576 0.0200
238 ANGIOPATHY 112 0.0200
239 PRODUCTIVE COUGH 944 0.0198
240 SEASONAL ALLERGY 279 0.0197
241 EXTRASYSTOLES 137 0.0196
242 CHOLECYSTITIS CHRONIC 131 0.0195
243 EYE PRURITUS 656 0.0195
244 MULTIPLE ALLERGIES 153 0.0195
245 VENTRICULAR FIBRILLATION 216 0.0194
246 MUSCULAR WEAKNESS 2193 0.0193
247 DIABETES MELLITUS 1466 0.0192
248 TOOTH FRACTURE 212 0.0192
249 ATRIAL FIBRILLATION 1869 0.0192
250 SUPRAVENTRICULAR TACHYCARDIA 183 0.0191
251 LYMPHOEDEMA 132 0.0191
252 VITAMIN D DEFICIENCY 186 0.0191
253 CORONARY ARTERY OCCLUSION 261 0.0190
254 MUSCLE STRAIN 164 0.0189
255 DYSARTHRIA 713 0.0189
256 TROPONIN INCREASED 144 0.0189
257 BONE DISORDER 344 0.0189
258 HAEMATEMESIS 478 0.0188
259 BLOOD CALCIUM INCREASED 165 0.0188
260 TENDON RUPTURE 232 0.0188
261 HYPOTENSION 3768 0.0188
262 EYE PAIN 1058 0.0187
263 VITAMIN D DECREASED 160 0.0187
264 PERIPHERAL SWELLING 2883 0.0187
265 RECTAL HAEMORRHAGE 802 0.0186
266 MICTURITION URGENCY 213 0.0186
267 HEART RATE INCREASED 1847 0.0186
268 DYSPNOEA EXERTIONAL 702 0.0186
269 BLOOD CALCIUM DECREASED 209 0.0186
270 SPINAL DISORDER 176 0.0186
271 SPUTUM DISCOLOURED 176 0.0185
272 INCONTINENCE 196 0.0185
273 CATARACT OPERATION 110 0.0185
274 DRUG INTERACTION 2935 0.0185
275 ACUTE MYOCARDIAL INFARCTION 545 0.0185
276 PERONEAL NERVE PALSY 105 0.0185
277 MYOCARDIAL ISCHAEMIA 210 0.0184
278 IRON DEFICIENCY ANAEMIA 170 0.0184
279 HAEMATURIA 628 0.0183
280 HYPOGLYCAEMIA 889 0.0183
281 URINARY INCONTINENCE 543 0.0183
282 LUNG INFILTRATION 161 0.0182
283 SQUAMOUS CELL CARCINOMA OF SKIN 110 0.0182
284 BLOOD URIC ACID INCREASED 105 0.0182
285 FOOT DEFORMITY 201 0.0181
286 BLOOD CREATININE INCREASED 1180 0.0181
287 CHOLELITHIASIS 592 0.0180
288 MENTAL STATUS CHANGES 501 0.0180
289 INITIAL INSOMNIA 185 0.0180
290 SCIATICA 287 0.0180
291 RHINITIS 145 0.0180
292 HYPOTHYROIDISM 574 0.0180
293 COGNITIVE DISORDER 839 0.0179
294 LOW DENSITY LIPOPROTEIN INCREASED 139 0.0179
295 POSTOPERATIVE WOUND INFECTION 121 0.0179
296 TACHYCARDIA 1588 0.0179
297 ATRIOVENTRICULAR BLOCK 138 0.0178
298 AMNESIA 1161 0.0178
299 ALTERED STATE OF CONSCIOUSNESS 386 0.0178
300 HYPOCALCAEMIA 337 0.0178
301 GROIN PAIN 156 0.0177
302 PROTHROMBIN TIME PROLONGED 106 0.0177
303 BLOOD IRON DECREASED 210 0.0177
304 JOINT DISLOCATION 187 0.0177
305 DYSURIA 651 0.0177
306 CHOLECYSTITIS 209 0.0175
307 CARDIAC FAILURE CONGESTIVE 1408 0.0175
308 HYPERGLYCAEMIA 637 0.0175
309 MUSCULOSKELETAL PAIN 914 0.0174
310 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 154 0.0174
311 SPINAL PAIN 204 0.0174
312 OLIGURIA 108 0.0174
313 BLOOD PRESSURE DECREASED 1154 0.0174
314 PALPITATIONS 2033 0.0173
315 FALL 5775 0.0173
316 IMPAIRED GASTRIC EMPTYING 236 0.0173
317 INCREASED TENDENCY TO BRUISE 159 0.0173
318 BRADYCARDIA 915 0.0172
319 BRONCHITIS 1271 0.0172
320 APHASIA 518 0.0171
321 ACUTE CORONARY SYNDROME 142 0.0171
322 GASTRITIS 451 0.0171
323 JOINT INJURY 366 0.0171
324 MUSCULOSKELETAL CHEST PAIN 265 0.0171
325 SKIN ULCER 442 0.0171
326 URINE OUTPUT DECREASED 149 0.0170
327 ULCER 271 0.0170
328 UROSEPSIS 157 0.0170
329 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 814 0.0169
330 RESPIRATORY RATE INCREASED 150 0.0169
331 PROCTALGIA 108 0.0168
332 CARDIOGENIC SHOCK 241 0.0168
333 MUSCULOSKELETAL DISCOMFORT 289 0.0168
334 JOINT SWELLING 2024 0.0168
335 LIMB INJURY 455 0.0167
336 ORAL PAIN 375 0.0167
337 DISTURBANCE IN ATTENTION 903 0.0167
338 WHEEZING 991 0.0167
339 PRODUCT ADMINISTRATION INTERRUPTED 131 0.0167
340 BACK DISORDER 271 0.0167
341 BACK PAIN 3872 0.0166
342 POLLAKIURIA 695 0.0166
343 CHEST PAIN 3086 0.0166
344 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 869 0.0166
345 SINUSITIS 1706 0.0166
346 HYPOPHOSPHATAEMIA 123 0.0166
347 PROCEDURAL PAIN 461 0.0166
348 BLADDER DISORDER 165 0.0166
349 ASCITES 486 0.0165
350 BREAST MASS 111 0.0165
351 BLOOD POTASSIUM INCREASED 268 0.0165
352 APHTHOUS ULCER 128 0.0165
353 COLITIS ISCHAEMIC 111 0.0164
354 RESTLESS LEGS SYNDROME 299 0.0164
355 RED BLOOD CELL COUNT DECREASED 470 0.0164
356 ATRIOVENTRICULAR BLOCK COMPLETE 110 0.0164
357 COUGH 4601 0.0164
358 CARDIO-RESPIRATORY ARREST 684 0.0163
359 IMPAIRED QUALITY OF LIFE 235 0.0163
360 SPINAL COMPRESSION FRACTURE 135 0.0163
361 ARTHROPATHY 904 0.0162
362 FREQUENT BOWEL MOVEMENTS 438 0.0162
363 RIB FRACTURE 333 0.0162
364 LIGAMENT SPRAIN 160 0.0162
365 HYPOXIA 569 0.0161
366 PULMONARY CONGESTION 213 0.0161
367 OESOPHAGITIS 176 0.0161
368 LOCAL SWELLING 281 0.0161
369 EAR PAIN 312 0.0160
370 BRONCHIECTASIS 108 0.0160
371 THYROID DISORDER 247 0.0160
372 GINGIVAL PAIN 127 0.0159
373 WALKING AID USER 105 0.0159
374 SHOCK 366 0.0159
375 NAIL DISORDER 139 0.0159
376 HYPOPHAGIA 406 0.0159
377 UTERINE LEIOMYOMA 116 0.0159
378 GALLBLADDER DISORDER 283 0.0158
379 RHABDOMYOLYSIS 661 0.0158
380 DYSPEPSIA 1558 0.0158
381 HAEMOPTYSIS 441 0.0158
382 WEIGHT DECREASED 4413 0.0158
383 ECCHYMOSIS 108 0.0157
384 RENAL IMPAIRMENT 1320 0.0157
385 TOOTH DISORDER 349 0.0157
386 GLAUCOMA 302 0.0157
387 HYPERHIDROSIS 2017 0.0156
388 OXYGEN SATURATION DECREASED 875 0.0156
389 HAEMATOCHEZIA 857 0.0155
390 RHINORRHOEA 1003 0.0155
391 CONCUSSION 120 0.0155
392 HEAD INJURY 490 0.0155
393 METABOLIC ACIDOSIS 494 0.0154
394 FLUSHING 1570 0.0154
395 BLOOD URINE PRESENT 293 0.0154
396 ATRIAL FLUTTER 123 0.0154
397 ASTHENIA 5795 0.0154
398 NEOPLASM 177 0.0154
399 NECK PAIN 858 0.0153
400 NEPHROLITHIASIS 704 0.0153
401 UPPER RESPIRATORY TRACT INFECTION 709 0.0153
402 MIDDLE INSOMNIA 286 0.0153
403 PAIN IN EXTREMITY 4511 0.0153
404 DIZZINESS 7629 0.0153
405 ARTHRALGIA 6349 0.0153
406 PLATELET COUNT INCREASED 199 0.0152
407 SYNOVITIS 274 0.0152
408 INFUSION RELATED REACTION 1006 0.0152
409 HAEMODIALYSIS 127 0.0151
410 EOSINOPHILIA 265 0.0151
411 AORTIC ANEURYSM 115 0.0151
412 HOT FLUSH 1138 0.0151
413 BLOOD COUNT ABNORMAL 228 0.0150
414 GASTROENTERITIS 219 0.0150
415 CONTUSION 1444 0.0150
416 LACERATION 141 0.0150
417 COLITIS 568 0.0150
418 ANOREXIA 193 0.0150
419 LEUKOCYTOSIS 271 0.0150
420 DRY MOUTH 1214 0.0149
421 HEPATOMEGALY 147 0.0149
422 PANCREATITIS 789 0.0149
423 SWOLLEN TONGUE 466 0.0149
424 BLOOD TESTOSTERONE DECREASED 102 0.0149
425 TENDERNESS 155 0.0149
426 ANXIETY 4232 0.0149
427 BALANCE DISORDER 1283 0.0148
428 HYPOTONIA 148 0.0148
429 RHEUMATOID ARTHRITIS 1679 0.0148
430 SKIN DISCOLOURATION 679 0.0148
431 INSOMNIA 3932 0.0147
432 GAIT DISTURBANCE 2823 0.0147
433 LOWER GASTROINTESTINAL HAEMORRHAGE 109 0.0147
434 ABDOMINAL PAIN UPPER 3034 0.0147
435 TONGUE DISORDER 106 0.0146
436 URINARY TRACT INFECTION 2491 0.0146
437 POOR VENOUS ACCESS 151 0.0146
438 ACUTE RESPIRATORY FAILURE 280 0.0145
439 CYST 180 0.0145
440 TOOTH INFECTION 191 0.0145
441 ANKLE FRACTURE 224 0.0145
442 FIBROMYALGIA 351 0.0144
443 WEIGHT FLUCTUATION 151 0.0144
444 DYSPHONIA 844 0.0144
445 CELLULITIS 726 0.0144
446 INFLUENZA 1606 0.0144
447 CONSTIPATION 3139 0.0144
448 KNEE ARTHROPLASTY 303 0.0144
449 PETECHIAE 150 0.0144
450 DENTAL CARIES 159 0.0144
451 SHOCK HAEMORRHAGIC 117 0.0144
452 PARKINSONISM 140 0.0143
453 POOR QUALITY SLEEP 309 0.0143
454 RETCHING 306 0.0143
455 PHARYNGITIS 178 0.0143
456 GLYCOSYLATED HAEMOGLOBIN INCREASED 362 0.0143
457 ARRHYTHMIA 678 0.0143
458 JOINT RANGE OF MOTION DECREASED 192 0.0143
459 SLUGGISHNESS 146 0.0143
460 ASTHMA 1617 0.0143
461 FOOT FRACTURE 271 0.0143
462 ALOPECIA 2803 0.0143
463 CHOLESTASIS 274 0.0143
464 CEREBROVASCULAR ACCIDENT 2417 0.0143
465 LOCALISED INFECTION 345 0.0143
466 INJECTION SITE EXTRAVASATION 176 0.0142
467 CONTRAINDICATED PRODUCT ADMINISTERED 431 0.0142
468 DIZZINESS POSTURAL 138 0.0142
469 ESCHERICHIA INFECTION 117 0.0142
470 PULMONARY HYPERTENSION 296 0.0142
471 SKIN LESION 389 0.0142
472 ARTHROPOD BITE 105 0.0142
473 INTERNATIONAL NORMALISED RATIO INCREASED 403 0.0141
474 ABASIA 349 0.0141
475 ANAL INCONTINENCE 127 0.0141
476 MEMORY IMPAIRMENT 1933 0.0141
477 ELECTROCARDIOGRAM QT PROLONGED 506 0.0141
478 PHOTOSENSITIVITY REACTION 232 0.0140
479 BACTERIAL INFECTION 261 0.0140
480 SKIN PLAQUE 118 0.0140
481 GINGIVAL BLEEDING 191 0.0140
482 NASAL CONGESTION 822 0.0140
483 FEAR 376 0.0140
484 DYSSTASIA 408 0.0140
485 CHEST DISCOMFORT 1428 0.0139
486 SINUS TACHYCARDIA 198 0.0139
487 NEURALGIA 339 0.0139
488 PROSTATIC SPECIFIC ANTIGEN INCREASED 192 0.0139
489 DYSPNOEA 7876 0.0139
490 AGEUSIA 347 0.0139
491 UPPER GASTROINTESTINAL HAEMORRHAGE 234 0.0139
492 ERECTILE DYSFUNCTION 357 0.0139
493 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 989 0.0139
494 LIMB DISCOMFORT 430 0.0139
495 HAEMATOMA 360 0.0139
496 BACK INJURY 151 0.0139
497 INFLAMMATION 716 0.0139
498 MUSCULOSKELETAL STIFFNESS 1215 0.0139
499 MYOCARDIAL INFARCTION 2419 0.0139
500 ABDOMINAL DISCOMFORT 2325 0.0138
501 UPPER LIMB FRACTURE 276 0.0138
502 WRIST FRACTURE 166 0.0138
503 BLOOD GLUCOSE INCREASED 2604 0.0138
504 DISORIENTATION 546 0.0138
505 NERVOUSNESS 719 0.0137
506 URINARY RETENTION 459 0.0137
507 CHOLECYSTECTOMY 157 0.0137
508 FLUID RETENTION 697 0.0137
509 FLATULENCE 777 0.0137
510 ABDOMINAL PAIN 3185 0.0137
511 CHROMATURIA 308 0.0136
512 ANAEMIA 2596 0.0136
513 INCREASED APPETITE 260 0.0136
514 MASS 190 0.0136
515 MUSCLE SPASMS 2487 0.0135
516 GASTRIC ULCER 257 0.0135
517 ADRENAL INSUFFICIENCY 164 0.0135
518 COMA 643 0.0135
519 DYSPHAGIA 1281 0.0135
520 DIARRHOEA 8711 0.0135
521 FEELING HOT 827 0.0135
522 CONFUSIONAL STATE 2180 0.0135
523 PELVIC FRACTURE 105 0.0135
524 HALLUCINATION 1016 0.0135
525 ACIDOSIS 103 0.0135
526 FATIGUE 10470 0.0134
527 WEIGHT INCREASED 3008 0.0134
528 HELICOBACTER INFECTION 138 0.0134
529 MELAENA 295 0.0134
530 NERVE INJURY 149 0.0134
531 VERTIGO 816 0.0134
532 BODY TEMPERATURE INCREASED 273 0.0134
533 ORAL HERPES 261 0.0134
534 HAEMOGLOBIN DECREASED 1370 0.0133
535 RASH PRURITIC 722 0.0133
536 MULTI-ORGAN FAILURE 230 0.0133
537 HYPOKINESIA 193 0.0133
538 MUSCLE TIGHTNESS 215 0.0133
539 WOUND 370 0.0132
540 HEREDITARY ANGIOEDEMA 142 0.0132
541 NEUROPATHY PERIPHERAL 1258 0.0132
542 CLOSTRIDIUM DIFFICILE COLITIS 140 0.0132
543 EYE INFECTION 149 0.0132
544 JOINT STIFFNESS 346 0.0132
545 EYE HAEMORRHAGE 176 0.0132
546 HIP FRACTURE 424 0.0132
547 DYSGEUSIA 979 0.0132
548 TENDONITIS 204 0.0132
549 GASTROINTESTINAL HAEMORRHAGE 1101 0.0132
550 ATAXIA 156 0.0131
551 OSTEOMYELITIS 238 0.0131
552 COAGULOPATHY 219 0.0131
553 PHARYNGEAL OEDEMA 202 0.0131
554 ANURIA 113 0.0131
555 MYALGIA 2229 0.0131
556 VISION BLURRED 1800 0.0131
557 WHITE BLOOD CELL COUNT INCREASED 502 0.0131
558 HEPATIC ENZYME INCREASED 891 0.0131
559 DERMATITIS CONTACT 149 0.0131
560 HYPOAESTHESIA 1953 0.0130
561 TOOTHACHE 236 0.0130
562 PARAESTHESIA 2050 0.0130
563 POST PROCEDURAL COMPLICATION 250 0.0130
564 MUSCLE DISORDER 105 0.0130
565 PERIPHERAL COLDNESS 178 0.0130
566 OEDEMA 703 0.0129
567 FULL BLOOD COUNT DECREASED 261 0.0129
568 EJECTION FRACTION DECREASED 201 0.0129
569 FEELING COLD 360 0.0129
570 PAIN 7943 0.0129
571 SMALL INTESTINAL OBSTRUCTION 159 0.0129
572 SWELLING 1208 0.0129
573 DECREASED APPETITE 2997 0.0129
574 DECREASED ACTIVITY 139 0.0129
575 CARDIOMYOPATHY 190 0.0128
576 CHILLS 1504 0.0128
577 TASTE DISORDER 260 0.0128
578 EPISTAXIS 958 0.0128
579 DEPRESSION 2912 0.0128
580 KIDNEY INFECTION 251 0.0128
581 ACTIVITIES OF DAILY LIVING IMPAIRED 253 0.0128
582 NAUSEA 10085 0.0127
583 RENAL PAIN 135 0.0127
584 VITREOUS FLOATERS 125 0.0127
585 SENSORY DISTURBANCE 204 0.0127
586 BLOOD ALKALINE PHOSPHATASE INCREASED 315 0.0127
587 RENAL DISORDER 591 0.0127
588 PERICARDIAL EFFUSION 292 0.0126
589 SCAB 144 0.0126
590 FAECES DISCOLOURED 273 0.0126
591 HEADACHE 7893 0.0126
592 COMPLETED SUICIDE 1049 0.0126
593 ISCHAEMIC STROKE 224 0.0125
594 LUNG DISORDER 615 0.0125
595 BLINDNESS UNILATERAL 177 0.0125
596 INTENTIONAL PRODUCT MISUSE 1097 0.0125
597 FEELING ABNORMAL 2991 0.0125
598 THROMBOSIS 1002 0.0124
599 ABDOMINAL DISTENSION 1299 0.0124
600 BURNING SENSATION 872 0.0124
601 DRY THROAT 126 0.0124
602 NASOPHARYNGITIS 2284 0.0124
603 DEAFNESS 324 0.0124
604 MALIGNANT MELANOMA 166 0.0124
605 PULMONARY THROMBOSIS 135 0.0124
606 INTENTIONAL PRODUCT USE ISSUE 1082 0.0123
607 ASPARTATE AMINOTRANSFERASE INCREASED 655 0.0123
608 C-REACTIVE PROTEIN INCREASED 448 0.0123
609 PRODUCT PRESCRIBING ERROR 293 0.0123
610 VOMITING 5777 0.0123
611 MALAISE 5387 0.0123
612 INJURY 863 0.0123
613 IMMUNODEFICIENCY 183 0.0123
614 SKIN CANCER 264 0.0122
615 ORAL DISCOMFORT 170 0.0122
616 PRURITUS GENERALISED 264 0.0122
617 SPLENOMEGALY 143 0.0122
618 COLD SWEAT 215 0.0122
619 SECRETION DISCHARGE 152 0.0121
620 SWELLING FACE 790 0.0121
621 DEMENTIA 339 0.0121
622 MUSCLE RIGIDITY 145 0.0121
623 VISUAL IMPAIRMENT 1496 0.0121
624 GASTRIC DISORDER 414 0.0121
625 GASTROINTESTINAL INFECTION 108 0.0120
626 PRURITUS 4628 0.0120
627 SOMNOLENCE 2423 0.0120
628 GRAND MAL CONVULSION 111 0.0120
629 DEEP VEIN THROMBOSIS 780 0.0120
630 OROPHARYNGEAL PAIN 1111 0.0120
631 PROTEINURIA 228 0.0120
632 BLOOD CREATINE PHOSPHOKINASE INCREASED 344 0.0119
633 SPEECH DISORDER 625 0.0119
634 CIRCULATORY COLLAPSE 203 0.0119
635 SKIN EXFOLIATION 1005 0.0119
636 HYPERTHYROIDISM 172 0.0119
637 FEMUR FRACTURE 367 0.0118
638 SCRATCH 125 0.0118
639 COVID-19 2072 0.0118
640 EYE DISORDER 388 0.0118
641 PAIN IN JAW 334 0.0118
642 IMPAIRED HEALING 387 0.0118
643 MIGRAINE 1121 0.0117
644 GASTROENTERITIS VIRAL 212 0.0117
645 PLEURAL EFFUSION 714 0.0117
646 INFLUENZA LIKE ILLNESS 964 0.0117
647 THROAT IRRITATION 525 0.0117
648 APHONIA 163 0.0117
649 LOSS OF CONSCIOUSNESS 1496 0.0117
650 ALANINE AMINOTRANSFERASE INCREASED 715 0.0116
651 SLEEP DISORDER 821 0.0116
652 HERPES ZOSTER 666 0.0116
653 ABNORMAL DREAMS 320 0.0116
654 KNEE OPERATION 114 0.0116
655 GASTROINTESTINAL DISORDER 1038 0.0116
656 CHOKING 226 0.0116
657 FUNGAL INFECTION 386 0.0116
658 ERUCTATION 224 0.0116
659 LETHARGY 666 0.0116
660 PULMONARY EMBOLISM 1100 0.0116
661 BONE PAIN 678 0.0116
662 DRY EYE 577 0.0115
663 SEPSIS 1289 0.0115
664 QUALITY OF LIFE DECREASED 155 0.0115
665 ABSCESS 184 0.0115
666 MOBILITY DECREASED 828 0.0115
667 STAPHYLOCOCCAL INFECTION 380 0.0115
668 RESPIRATORY TRACT INFECTION 300 0.0115
669 SCAR 197 0.0115
670 BIPOLAR DISORDER 125 0.0115
671 BLOOD GLUCOSE FLUCTUATION 126 0.0115
672 EAR DISCOMFORT 118 0.0115
673 MOVEMENT DISORDER 368 0.0114
674 EYE SWELLING 426 0.0114
675 MUSCLE ATROPHY 145 0.0114
676 BREAST PAIN 122 0.0114
677 HEPATIC CIRRHOSIS 214 0.0114
678 PYREXIA 3928 0.0113
679 TOOTH EXTRACTION 141 0.0113
680 EYE INFLAMMATION 108 0.0113
681 PNEUMONIA 3663 0.0113
682 THIRST 202 0.0113
683 ENCEPHALOPATHY 276 0.0112
684 DRUG LEVEL INCREASED 186 0.0112
685 SPINAL OPERATION 138 0.0112
686 TREMOR 1857 0.0112
687 EYE DISCHARGE 116 0.0112
688 RESPIRATORY FAILURE 809 0.0111
689 CARDIAC FAILURE 890 0.0111
690 VIRAL INFECTION 368 0.0110
691 STOMATITIS 668 0.0110
692 GENERAL PHYSICAL HEALTH DETERIORATION 1272 0.0110
693 FEELING JITTERY 209 0.0110
694 PNEUMONIA ASPIRATION 273 0.0109
695 NIGHT SWEATS 352 0.0109
696 RESPIRATORY DISTRESS 301 0.0109
697 APATHY 159 0.0109
698 SKIN INFECTION 122 0.0109
699 RASH MACULAR 380 0.0109
700 ACUTE RESPIRATORY DISTRESS SYNDROME 192 0.0108
701 PULMONARY OEDEMA 485 0.0108
702 BLOOD GLUCOSE ABNORMAL 200 0.0108
703 INTRAOCULAR PRESSURE INCREASED 138 0.0108
704 GAMMA-GLUTAMYLTRANSFERASE INCREASED 239 0.0108
705 HYPERSOMNIA 309 0.0108
706 ROAD TRAFFIC ACCIDENT 450 0.0107
707 COVID-19 PNEUMONIA 127 0.0107
708 HEPATITIS 275 0.0107
709 PHARMACEUTICAL PRODUCT COMPLAINT 279 0.0107
710 IMPAIRED DRIVING ABILITY 122 0.0107
711 MALNUTRITION 120 0.0107
712 EAR INFECTION 284 0.0107
713 DRY SKIN 1422 0.0106
714 GAIT INABILITY 356 0.0106
715 MYOCLONUS 127 0.0106
716 INFUSION SITE PAIN 137 0.0106
717 LACRIMATION INCREASED 321 0.0106
718 UNRESPONSIVE TO STIMULI 273 0.0106
719 BEDRIDDEN 139 0.0106
720 TEMPERATURE INTOLERANCE 109 0.0106
721 MUSCULOSKELETAL DISORDER 201 0.0105
722 DERMATITIS 221 0.0105
723 IRRITABLE BOWEL SYNDROME 226 0.0105
724 BLOOD BILIRUBIN INCREASED 283 0.0105
725 BLISTER 588 0.0105
726 BLOOD TEST ABNORMAL 147 0.0105
727 BLOOD GLUCOSE DECREASED 502 0.0104
728 PRESCRIBED UNDERDOSE 208 0.0104
729 SUBDURAL HAEMATOMA 149 0.0104
730 LYMPHADENOPATHY 368 0.0104
731 PRODUCT ADMINISTRATION ERROR 210 0.0104
732 DISEASE RECURRENCE 494 0.0104
733 GLOSSODYNIA 232 0.0104
734 DRUG TOXICITY 141 0.0103
735 INTENTIONAL DOSE OMISSION 295 0.0103
736 VISUAL ACUITY REDUCED 342 0.0103
737 CANDIDA INFECTION 173 0.0102
738 ABDOMINAL PAIN LOWER 259 0.0102
739 HERNIA 197 0.0102
740 INJECTION SITE NODULE 112 0.0102
741 THERAPEUTIC RESPONSE UNEXPECTED 455 0.0101
742 SPINAL FRACTURE 203 0.0101
743 RASH MACULO-PAPULAR 223 0.0100
744 PSORIASIS 1308 0.0100
745 CARDIAC DISORDER 935 0.0100
746 PANIC ATTACK 363 0.0099
747 DIABETIC KETOACIDOSIS 239 0.0099
748 THERAPEUTIC PRODUCT EFFECT DECREASED 445 0.0099
749 DRUG ERUPTION 176 0.0099
750 INJECTION SITE DISCOLOURATION 124 0.0099
751 OCULAR HYPERAEMIA 470 0.0099
752 LABORATORY TEST ABNORMAL 292 0.0099
753 SEPTIC SHOCK 430 0.0099
754 FEEDING DISORDER 200 0.0099
755 UNEVALUABLE EVENT 744 0.0098
756 HEPATIC CYTOLYSIS 125 0.0098
757 EYE IRRITATION 563 0.0098
758 SKIN DISORDER 325 0.0097
759 SUDDEN DEATH 103 0.0097
760 PLATELET COUNT DECREASED 1037 0.0097
761 RESPIRATORY DISORDER 291 0.0097
762 THROAT TIGHTNESS 263 0.0097
763 SKIN FISSURES 190 0.0097
764 WOUND INFECTION 106 0.0097
765 DRUG INTOLERANCE 934 0.0097
766 CONDITION AGGRAVATED 2936 0.0096
767 PALLOR 262 0.0096
768 METASTASES TO LUNG 111 0.0096
769 COLITIS ULCERATIVE 429 0.0096
770 METASTASES TO LIVER 168 0.0095
771 INTESTINAL OBSTRUCTION 360 0.0095
772 FACE OEDEMA 161 0.0095
773 GASTROINTESTINAL PAIN 105 0.0095
774 DISCOMFORT 581 0.0095
775 WHITE BLOOD CELL COUNT DECREASED 1032 0.0095
776 ERYTHEMA 1956 0.0095
777 JAUNDICE 256 0.0095
778 TACHYPNOEA 129 0.0095
779 WRONG TECHNIQUE IN DRUG USAGE PROCESS 344 0.0095
780 NIGHTMARE 327 0.0094
781 PARALYSIS 135 0.0094
782 RASH 4102 0.0094
783 MOUTH ULCERATION 197 0.0093
784 PSORIATIC ARTHROPATHY 379 0.0093
785 BRAIN FOG 146 0.0093
786 HYPERSENSITIVITY 1724 0.0093
787 HALLUCINATION, VISUAL 196 0.0093
788 CRYING 337 0.0093
789 INSURANCE ISSUE 141 0.0092
790 PRODUCT DOSE OMISSION IN ERROR 261 0.0092
791 LIVER FUNCTION TEST ABNORMAL 267 0.0092
792 EMOTIONAL DISTRESS 1110 0.0092
793 HYPOAESTHESIA ORAL 138 0.0091
794 DERMATITIS ALLERGIC 115 0.0091
795 PANCYTOPENIA 509 0.0091
796 POST PROCEDURAL HAEMORRHAGE 106 0.0091
797 HYPOACUSIS 391 0.0091
798 TREATMENT NONCOMPLIANCE 495 0.0090
799 RESTLESSNESS 331 0.0090
800 DELIRIUM 312 0.0090
801 FLUID OVERLOAD 130 0.0089
802 BRONCHOSPASM 127 0.0089
803 LOWER LIMB FRACTURE 171 0.0089
804 STEVENS-JOHNSON SYNDROME 197 0.0089
805 HIP ARTHROPLASTY 135 0.0088
806 CEREBRAL INFARCTION 215 0.0088
807 ILEUS 109 0.0088
808 POLYNEUROPATHY 105 0.0088
809 THINKING ABNORMAL 162 0.0087
810 DEPRESSED MOOD 459 0.0087
811 METASTASES TO BONE 142 0.0086
812 MUCOSAL INFLAMMATION 226 0.0086
813 ILLNESS 886 0.0086
814 MULTIPLE FRACTURES 141 0.0086
815 ACCIDENT 102 0.0085
816 THERAPEUTIC RESPONSE DECREASED 515 0.0085
817 LYMPHOCYTE COUNT DECREASED 150 0.0085
818 CONVULSION 485 0.0085
819 CYANOSIS 133 0.0084
820 CARDIAC ARREST 690 0.0083
821 LIVER DISORDER 370 0.0083
822 RASH GENERALISED 216 0.0083
823 PNEUMOTHORAX 132 0.0083
824 SURGERY 488 0.0083
825 URTICARIA 1393 0.0083
826 LIVER FUNCTION TEST INCREASED 178 0.0083
827 HUNGER 115 0.0082
828 FRACTURE 156 0.0082
829 PARANOIA 142 0.0082
830 PNEUMONITIS 224 0.0082
831 INJECTION SITE MASS 304 0.0082
832 SEDATION 215 0.0082
833 MANIA 135 0.0082
834 PELVIC PAIN 148 0.0081
835 SEROTONIN SYNDROME 156 0.0081
836 RASH ERYTHEMATOUS 388 0.0081
837 DEPRESSED LEVEL OF CONSCIOUSNESS 321 0.0081
838 INFECTION 1171 0.0081
839 EMOTIONAL DISORDER 249 0.0081
840 TOXICITY TO VARIOUS AGENTS 1355 0.0080
841 ILL-DEFINED DISORDER 483 0.0079
842 PRODUCT DOSE OMISSION 516 0.0079
843 LYMPHOMA 122 0.0079
844 DIALYSIS 112 0.0079
845 DRUG EFFECT DECREASED 425 0.0079
846 MENTAL DISORDER 343 0.0079
847 CLOSTRIDIUM DIFFICILE INFECTION 172 0.0079
848 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 183 0.0078
849 PRODUCT AVAILABILITY ISSUE 178 0.0078
850 AGITATION 574 0.0078
851 RESPIRATORY ARREST 215 0.0078
852 CARDIOVASCULAR DISORDER 198 0.0078
853 NEOPLASM PROGRESSION 270 0.0078
854 CONJUNCTIVITIS 144 0.0078
855 THROMBOCYTOPENIA 866 0.0077
856 CEREBRAL HAEMORRHAGE 277 0.0077
857 DRUG ADMINISTRATION ERROR 237 0.0077
858 ANGER 261 0.0077
859 LYMPHOPENIA 109 0.0077
860 DYSKINESIA 311 0.0076
861 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 542 0.0076
862 HEPATOCELLULAR INJURY 108 0.0076
863 ECZEMA 398 0.0076
864 DRUG EFFECT INCOMPLETE 276 0.0076
865 LUNG INFECTION 118 0.0076
866 FEBRILE NEUTROPENIA 502 0.0076
867 BONE DENSITY DECREASED 237 0.0076
868 NERVOUS SYSTEM DISORDER 236 0.0076
869 DELUSION 117 0.0075
870 SYSTEMIC LUPUS ERYTHEMATOSUS 267 0.0075
871 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 193 0.0075
872 HEPATIC FAILURE 226 0.0075
873 NEEDLE ISSUE 218 0.0075
874 DRUG INEFFECTIVE 9767 0.0074
875 OSTEONECROSIS OF JAW 183 0.0074
876 MENTAL IMPAIRMENT 179 0.0074
877 DRUG-INDUCED LIVER INJURY 231 0.0074
878 INJECTION SITE PRURITUS 491 0.0073
879 HEPATOTOXICITY 163 0.0073
880 THERAPY CESSATION 373 0.0073
881 IMPAIRED WORK ABILITY 155 0.0072
882 TOOTH LOSS 150 0.0072
883 INTENTIONAL OVERDOSE 464 0.0072
884 PRODUCT USE ISSUE 1352 0.0072
885 HAEMORRHAGE 750 0.0072
886 INCORRECT PRODUCT ADMINISTRATION DURATION 155 0.0071
887 LOWER RESPIRATORY TRACT INFECTION 325 0.0071
888 PRESCRIBED OVERDOSE 138 0.0071
889 INJECTION SITE HAEMATOMA 103 0.0071
890 IRRITABILITY 425 0.0071
891 TRANSAMINASES INCREASED 157 0.0071
892 PRODUCT DOSE OMISSION ISSUE 2063 0.0070
893 MEDICATION ERROR 389 0.0070
894 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1255 0.0070
895 DISABILITY 137 0.0069
896 HALLUCINATION, AUDITORY 110 0.0069
897 COLON CANCER 103 0.0069
898 OFF LABEL USE 6034 0.0069
899 DRUG DOSE OMISSION 1138 0.0069
900 SUICIDAL IDEATION 622 0.0068
901 GENERALISED TONIC-CLONIC SEIZURE 112 0.0068
902 PRODUCT QUALITY ISSUE 912 0.0067
903 MOOD ALTERED 183 0.0067
904 APPLICATION SITE PRURITUS 152 0.0067
905 SUICIDE ATTEMPT 406 0.0067
906 PSYCHOMOTOR HYPERACTIVITY 111 0.0067
907 BREAST CANCER FEMALE 178 0.0067
908 THERAPY INTERRUPTED 473 0.0066
909 MULTIPLE SCLEROSIS 316 0.0066
910 THERAPEUTIC RESPONSE SHORTENED 218 0.0066
911 ACCIDENTAL OVERDOSE 240 0.0066
912 ADVERSE DRUG REACTION 588 0.0065
913 INCORRECT DRUG ADMINISTRATION DURATION 184 0.0065
914 DISEASE PROGRESSION 773 0.0065
915 PRODUCT PHYSICAL ISSUE 131 0.0065
916 INJECTION SITE WARMTH 133 0.0065
917 INJECTION SITE HAEMORRHAGE 511 0.0064
918 ANAPHYLACTIC REACTION 352 0.0064
919 MULTIPLE SCLEROSIS RELAPSE 433 0.0063
920 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 346 0.0063
921 MULTIPLE ORGAN DYSFUNCTION SYNDROME 178 0.0063
922 INJECTION SITE BRUISING 501 0.0063
923 INTENTIONAL DRUG MISUSE 131 0.0063
924 NEUTROPHIL COUNT DECREASED 255 0.0063
925 PRODUCT SUBSTITUTION ISSUE 360 0.0062
926 INJECTION SITE PAIN 1873 0.0061
927 DRUG PRESCRIBING ERROR 117 0.0061
928 LEUKOPENIA 303 0.0061
929 APPLICATION SITE ERYTHEMA 157 0.0060
930 PRODUCT USE IN UNAPPROVED INDICATION 1483 0.0060
931 MOOD SWINGS 190 0.0060
932 EXPIRED PRODUCT ADMINISTERED 198 0.0060
933 ABNORMAL BEHAVIOUR 236 0.0060
934 WITHDRAWAL SYNDROME 246 0.0059
935 TARDIVE DYSKINESIA 165 0.0058
936 INJECTION SITE ERYTHEMA 722 0.0058
937 INJECTION SITE SWELLING 444 0.0058
938 LIVER INJURY 142 0.0058
939 INJECTION SITE URTICARIA 141 0.0057
940 PRODUCT DISPENSING ERROR 125 0.0057
941 OSTEONECROSIS 188 0.0057
942 VAGINAL HAEMORRHAGE 248 0.0057
943 INCORRECT DOSE ADMINISTERED 1300 0.0057
944 MALIGNANT NEOPLASM PROGRESSION 583 0.0057
945 PSYCHOTIC DISORDER 167 0.0056
946 APPLICATION SITE PAIN 124 0.0056
947 UNDERDOSE 410 0.0056
948 NEUTROPENIA 754 0.0055
949 INJECTION SITE REACTION 377 0.0055
950 NEOPLASM MALIGNANT 364 0.0054
951 SEIZURE 618 0.0053
952 INJECTION SITE RASH 164 0.0053
953 ADVERSE EVENT 485 0.0053
954 DERMATITIS ATOPIC 273 0.0052
955 EXTRAPYRAMIDAL DISORDER 128 0.0051
956 LUNG NEOPLASM MALIGNANT 207 0.0050
957 BREAST CANCER 464 0.0050
958 INTERSTITIAL LUNG DISEASE 241 0.0050
959 ANAPHYLACTIC SHOCK 126 0.0049
960 THERAPY NON-RESPONDER 219 0.0049
961 PLASMA CELL MYELOMA 189 0.0048
962 AGGRESSION 242 0.0048
963 TREATMENT FAILURE 382 0.0046
964 DEVICE MALFUNCTION 317 0.0045
965 SKIN BURNING SENSATION 319 0.0044
966 HOSPITALISATION 673 0.0044
967 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 873 0.0043
968 OVERDOSE 916 0.0042
969 PANCREATIC CARCINOMA 119 0.0041
970 DEVICE ISSUE 362 0.0040
971 SKIN IRRITATION 178 0.0039
972 HEPATIC FUNCTION ABNORMAL 140 0.0037
973 DRUG WITHDRAWAL SYNDROME 320 0.0036
974 DEATH 3102 0.0036
975 EXTRA DOSE ADMINISTERED 143 0.0035
976 PREMATURE BABY 106 0.0035
977 ACNE 258 0.0034
978 PRODUCT ADHESION ISSUE 120 0.0034
979 DEVICE BREAKAGE 136 0.0033
980 INCORRECT ROUTE OF DRUG ADMINISTRATION 113 0.0032
981 PROSTATE CANCER 252 0.0031
982 DEVICE DISLOCATION 126 0.0029
983 FOETAL EXPOSURE DURING PREGNANCY 220 0.0027
984 NO ADVERSE EVENT 482 0.0027
985 ACCIDENTAL EXPOSURE TO PRODUCT 272 0.0026
986 RENAL CANCER 111 0.0023
987 DRUG ABUSE 193 0.0023
988 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 107 0.0023
989 EXPOSURE DURING PREGNANCY 119 0.0019
990 PRODUCT STORAGE ERROR 163 0.0019
991 DRUG DEPENDENCE 295 0.0018
992 BLADDER CANCER 106 0.0018
993 DRUG DOSE OMISSION BY DEVICE 120 0.0015
994 MATERNAL EXPOSURE DURING PREGNANCY 122 0.0014